Replies to post #373823 on Amarin Corp Plc (AMRN)

[studythosestocks]

Thx Raf. We are hanging above 70k still. Important psychological marker IMO

[invest2992]

unbelievable. let's hope it is the start of a new trend.

[couldbebetter]

Very Nice! Finally some relief...I hope this continues.

[Bolio98]

Wow. A gain on the gV boys for a change. CVS kicking in maybe?

[dukesking]

Thanks Raf. This is a trend I can live with. Looks like things may be swinging in AMRNS favor. Maybe KM’s marketing, business plans and legal strategies are starting to pay off.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Birdbrain Ideas]

Thanks, as always, for the scripts. And I take back most of the whining I did after looking at last week's numbers. It does make me wonder how the trend can vary so wildly from one week to the next.

Remember when there was only Hikma's generic? And every other week they would rise 25 percent? And then on the off weeks they would drop 20 percent? I hope that variance isn't still in play, which would explain the total reversal since last week. Surprised to see Lovaza's numbers drop too.

Let's hope there was a positive development we're not aware of that gave us a boost, even on a week when drug industry scripts overall were dropping. I guess the numbers next week might give us a clearer indication.

One good thing about this stretch from late February to late May is that it's really the only time all year when we have so many weeks in a row without a weekday holiday.

[rafunrafun]

Scripts for week ending March 25, 2022

Drug Industry TRx: -1.1% w/w; +8.5% y/y

Vascepa
TRx 69,986; -4.1% (-2,990) w/w; -15.8% y/y
NRx 32,432; -3.6% (-1,205) w/w; -16.5% y/y
Ref 37,554; -4.5% (-1,784) w/w; -15.2% y/y

Lovaza (Generic & Brand)
TRx 61,708; -2.6% (-1,665) w/w; -0.6% y/y
NRx 32,589; -1.5% (-500) w/w; +4.0% y/y
Ref 29,119; -3.8% (-1,165) w/w; -5.2% y/y

Generic Vascepa
TRx 30,492; -0.5% (-161) w/w; As % of total V: 30.3%
NRx 16,684; -2.3% (-392) w/w; As % of total V: 34.0%
Ref 13,808; +1.7% (+231) w/w; As % of total V: 26.9%

Generic Vascepa by Manufacturer
Hikma - TRx 7,260; (-280) w/w; Generic share 23.8%; Total V share 7.2%
Reddy - TRx 13,867; (-244) w/w; Generic share 45.5%; Total V share 13.8%
Apotex - TRx 9,365; (+363) w/w; Generic share 30.7%; Total V share 9.3%

Vascepa + Generic Vascepa
TRx 100,478; -3.0% (-3,151) w/w; +8.3% y/y
NRx 49,117; -3.1% (-1,597) w/w; +10.6% y/y
Ref 51,362; -2.9% (-1,553) w/w; +6.2% y/y